| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $871.7M | +4.9% |
| R&D Expense | $19.8M | -30.5% |
| SG&A Expense | $157.7M | -6.2% |
| Operating Income | $236.0M | +17.8% |
| Interest Expense | $14.7M | +0.0% |
| Pre-tax Income | $144.8M | +31.9% |
| Income Tax | $27.6M | +125.3% |
| Net Income | $114.4M | +1.4% |
| EPS (Basic) | $1.07 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $96.5M | +3.2% |
| Accounts Receivable | $93.8M | -5.1% |
| Inventory | $73.8M | -9.3% |
| Current Assets | $276.5M | -5.5% |
| Total Assets | $2.53B | -5.3% |
| Current Liabilities | $111.7M | -34.0% |
| Long-term Debt | $1.76B | -0.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $400.1M | +6.4% |
| Capital Expenditures | $100.3M | +43.5% |
| Investing Cash Flow | -$100.3M | +44.5% |
| Financing Cash Flow | -$299.9M | -75.9% |
| Free Cash Flow | $299.8M | -2.0% |
| +12.6% |
| EPS (Diluted) | $1.06 | +12.8% |
| Total Liabilities |
| $2.07B |
| -1.3% |
| Stockholders' Equity | $462.6M | -19.8% |